Munson Health
 
Medications for Metabolic Syndrome

Back to Document

by Safer D
 

References


Brazg R, Xu L, Dalla Man C, et al. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes. Diabetes Obes Metab . 2007;9:186-93.


Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev . 2008;29:777-822.


Despres JP, Golay A, Sjostrom L, et al. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med . 2005;353:2121-2134.


Diabetes mellitus type 2. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what . Updated April 26, 2013. Accessed May 10, 2013.


Fibric acid derivatives. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what . Updated March 4, 2013. Accessed May 10, 2013.


Freemark M. Pharmacotherapy of childhood obesity. Diabetes Care . 2007;30:395-402.


How is metabolic syndrome treated? National Heart, Lung, and Blood Institute website. Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/ms/treatment.html . Updated November 3, 2011. Accessed May 10, 2013.


Hypertension. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what . Updated March 22, 2013. Accessed May 10, 2013.


Hypertriglyceridemia. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what . Updated January 17, 2013. Accessed May 10, 2013.


Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med . 2005;142:532-546.


Medication. American Diabetes Association website. Available at: http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/ . Accessed May 10, 2013.


Metabolic syndrome. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated March 29, 2013. Accessed May 10, 2013.


Orchar TJ, Temprosa M, Goldberg R, et al. The effect of diet and exercise or metformin on the metabolic syndrome: The diabetes prevention program randomized trial. Annals of Internal Medicine . 2005;142:611-619.


Rosenstock J, Fitchet M. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes. Int J Clin Pract Suppl . 2008;159:15-23.


Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother . 2008; 9:1237-1248.


Steinberger J, Daniels SR, Eckel RH, et al. AHA Scienfic Statement: Progress and Challenges in Metabolic Syndrome in children and Adolescents. Circulation . 2009;118:628-647.


Types of blood pressure medications. American Heart Association website. Available at: http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/PreventionTreatmentofHighBloodPressure/Types-of-Blood-Pressure-Medications%5FUCM%5F303247%5FArticle.jsp . Updated August 14, 2012. Accessed May 10, 2013.

 

Revision Information